Drug Infusion Systems Market Delivering Precision Care: The Booming Drug Infusion Systems Market

Drug Infusion Systems Market Assessment worth $ 23.27 Billion by 2030 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Drug Infusion Systems Market- by Product (Large Volume Infusion Systems, Patient-Controlled Analgesia, Elastomeric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Systems, Implantable Infusion Systems, Ambulatory Infusion Systems and Enteral Infusion Systems), Application (Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Haematology, Paediatrics and Other Applications), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1271

The drug infusion systems market is poised for significant growth in the coming years. According to a recent analysis by InsightAce Analytic, the market is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2024 to 2031, reaching a valuation of US$23.27 billion by 2030. This growth is attributed to the increasing use of infusion systems for administering a wide range of medications, including opioids, insulin, chemotherapeutic agents, and antibiotics.

Drug infusion systems, essentially pumps, deliver fluids, nutrients, or medications directly into a patient's bloodstream. They are typically administered intravenously (IV) for treating or managing various conditions, particularly neurological disorders. In some cases, they may also be used for epidural and arterial infusions.

The rapidly rising demand for safe and accurate drug delivery systems and the increasing frequency of chronic diseases and disorders in countries throughout the world are likely to drive revenue growth in the global drug infusion systems market. A drug infusion system capable of providing a fluid medicine, including a number of drugs,

to the patient under the sustenance of a healthcare expert. These systems are used to provide a specific dosage of a medicine, and the technology calculates the resulting medicine dosage and displays it to the physician. Such advantages of medication infusion systems for giving pharmaceuticals to patients safely and precisely are predicted to enhance acceptance in the healthcare business.

Another factor projected to boost global drug infusion systems market revenue growth in the coming years is the increasing use of medication infusion systems for chronic pain management. Diabetes prevalence has been rapidly increasing internationally, and this is likely to increase demand for medication infusion systems for treatment, boosting market growth over the forecast period. The rising demand for drug infusion systems for hemodynamic control is expected to drive revenue growth in the global drug infusion systems market in the coming years.

North America is anticipated to be the major contributor to the Drug Infusion Systems market over the forecast years because chronic disease prevalence is increasing in countries such as the United States and Canada Furthermore, the increasing number of procedures conducted in hospitals is likely to fuel regional market expansion. In addition,

the Asia Pacific Drug Infusion Systems market is expected to grow significantly during the forecast period due to the rising frequency of diabetes and cancer in the region's countries. Furthermore, increased government expenditure in the healthcare industry for adopting technologically advanced medical equipment is likely to drive the growth of the Asia Pacific market in the near future.

Major market players operating in the Drug Infusion Systems market include
Acromed AG, B. Braun Melsungen AG, Becton, Dickinson and Company, Baxter International Inc., Caesarea Medical Electronics Ltd., Flowonix Medical Inc., Fresenius SE & Co. KGaA, Debiotech S.A., Halyard Health, Inc., IRADIMED CORPORATION, Insulet Corporation, Medtronic, ICU Medical Inc., MOOG, Inc., Smiths Group plc, Tandem Diabetes Care, Inc., Terumo Corporation and Zyno Medical, LLC among others.

Recent collaborations and agreements in the market:
• In August 2021, Smiths Medical and Ivenix announced a collaboration on best-in-class infusion management technology to improve the infusion administration process.

• In July 2021, Innovative Health Sciences announced the CE mark for a syringe infusion system.

• In May 2020,International Baxter Inc. The Evo IQ Infusion System has acquired CE certification and regulatory approval from Australia's Therapeutic Goods Administration, according to Baxter International Inc., a global pioneer in advanced drug delivery technology (TGA). With the release of the Evo IQ Infusion System, there is now a wider range of infusion therapy options for different types of patients.

• In January 2020, Medtronic (Ireland) released Efficio, a cloud-based data management software designed to work with the SynchroMed II intrathecal medication delivery system. This allows clinicians to manage their targeted medication delivery pump procedures more efficiently while treating patients with chronic pain, cancer, and severe spasticity.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1271

Market Segments
Global Drug Infusion Systems Market, by Product Type, 2022-2030 (Value US$ Mn)
• Large Volume Infusion Systems
• Patient-Controlled Analgesia
• Elastomeric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Systems
• Implantable Infusion Systems
• Ambulatory Infusion Systems
• Enteral Infusion Systems

Global Drug Infusion Systems Market, by Application, 2022-2030 (Value US$ Mn)
• Oncology/Chemotherapy
• Diabetes
• Analgesia
• Nutrition
• Haematology
• Paediatrics
• Other Applications

Global Drug Infusion Systems Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada

Europe Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Drug Infusion Systems market
 To receive an industry overview and future trends of the Drug Infusion Systems market
 To analyze the Drug Infusion Systems market drivers and challenges
 To get information on the Drug Infusion Systems market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Drug Infusion Systems market industry

For More Customization @ https://www.insightaceanalytic.com/customisation/1271

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.